Cargando…
Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521946/ https://www.ncbi.nlm.nih.gov/pubmed/36629159 http://dx.doi.org/10.4103/aja2022114 |
| _version_ | 1785110251466391552 |
|---|---|
| author | Busetto, Gian Maria Falagario, Ugo Giovanni Carrieri, Giuseppe |
| author_facet | Busetto, Gian Maria Falagario, Ugo Giovanni Carrieri, Giuseppe |
| author_sort | Busetto, Gian Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10521946 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105219462023-09-27 Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” Busetto, Gian Maria Falagario, Ugo Giovanni Carrieri, Giuseppe Asian J Androl Invited Commentary Wolters Kluwer - Medknow 2023-01-10 /pmc/articles/PMC10521946/ /pubmed/36629159 http://dx.doi.org/10.4103/aja2022114 Text en Copyright: © The Author(s)(2023) https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Invited Commentary Busetto, Gian Maria Falagario, Ugo Giovanni Carrieri, Giuseppe Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” |
| title | Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” |
| title_full | Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” |
| title_fullStr | Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” |
| title_full_unstemmed | Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” |
| title_short | Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” |
| title_sort | commentary on “clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” |
| topic | Invited Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521946/ https://www.ncbi.nlm.nih.gov/pubmed/36629159 http://dx.doi.org/10.4103/aja2022114 |
| work_keys_str_mv | AT busettogianmaria commentaryonclinicalimplicationsofendogenoustestosteronedensityinprostatecancerprogressioninpatientswithfavorablelowandintermediaterisktreatedwithradicalprostatectomy AT falagariougogiovanni commentaryonclinicalimplicationsofendogenoustestosteronedensityinprostatecancerprogressioninpatientswithfavorablelowandintermediaterisktreatedwithradicalprostatectomy AT carrierigiuseppe commentaryonclinicalimplicationsofendogenoustestosteronedensityinprostatecancerprogressioninpatientswithfavorablelowandintermediaterisktreatedwithradicalprostatectomy |